Xerostomia in patients with advanced cancer

A N Davies, K Broadley, D Beighton

    Research output: Contribution to journalArticlepeer-review

    77 Citations (Scopus)

    Abstract

    The aim Of the study Was to investigate the features of xerostomia in patients with advanced cancer. The protocol involved completion of the Memorial Symptom Assessment Scale, and measurement of the unstimulated whole salivary flow rate (UWSFR) and the stimulated whole salivary flow rate (SWSFR). One hundred twenty patients participated in the study. Xerostomia was the fourth most common symptom (78% of patients). It was associated with a poor performance status (P = 0.01). The usual cause of xerostomia was drug treatment. There was an association with the total number of drags prescribed (P = 0.009): the median number of xerostomic drugs prescribed was 4. Xerostomia was ranked the third most distressing symptom. Its severity was correlated with the severity of oral discomfort, dysgeusia, dysmasesia, dysphagia, dysphonia, and anorexia. The UWSFR was a relatively sensitive, but nonspecific, investigation. In contrast, the SWSFR was a relatively specific, but insensitive, investigation. (C) U.S. Cancer Pain Relief Committee, 2001.
    Original languageEnglish
    Pages (from-to)820 - 825
    Number of pages6
    JournalJournal of Pain and Symptom Management
    Volume22
    Issue number4
    DOIs
    Publication statusPublished - 2001

    Fingerprint

    Dive into the research topics of 'Xerostomia in patients with advanced cancer'. Together they form a unique fingerprint.

    Cite this